Therapeutics (TGTX) 2025 Earnings Outlook for Investors
TG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Assess which Sp 500 fund is best for IRAs in 2024 using simple criteria, performance context, and fee awareness for smarter selection.
24,414 articlesTG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Investors are watching Innovative Industrial Properties stock climb this week as earnings and leasing momentum paint ...
When a niche space-data stock jumps, investors want to know the real reasons behind the move. This guide explains why...
A Blackstone executive made revealing private credit comments, triggering investor debate on liquidity and risk. Anal...
When a Cheesecake Factory executive moved nearly 4,800 shares, it stirred questions about CAKE stock. This guide brea...
Three consumer-facing stocks — Planet Fitness, Brown-Forman, and Campbell’s — moved on earnings, tariffs, and margin ...
Executives from banking, asset management, and consulting gathered at Hampton Court Palace to launch a private-sector...
Capricor's small-cap biotech story hinges on milestones, cash runway, and clinical progress. This guide breaks down w...
A government inquiry surfaces a document detailing a $5 million deal connected to Milei's Libra promotion, raising qu...
Could carnival millionaire-maker stock? actually turn a small position into a meaningful gain? This guide weighs upsi...
As Rivian gears up for the upcoming earnings release, two major catalysts could shape the stock's trajectory. This gu...
Swarmer’s 520% debut gain transformed a modest-revenue drone-software company into a market curiosity. With no analys...